Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

In the past 8 years, both the International Working Group (IWG) and the US National Institute on Aging–Alzheimer's Association have contributed criteria for the diagnosis of Alzheimer's disease (AD) that better define clinical phenotypes and integrate biomarkers into the diagnostic process...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lancet neurology Jg. 13; H. 6; S. 614 - 629
Hauptverfasser:	Dubois, Bruno, Feldman, Howard H, Jacova, Claudia, Hampel, Harald, Molinuevo, José Luis, Blennow, Kaj, DeKosky, Steven T, Gauthier, Serge, Selkoe, Dennis, Bateman, Randall, Cappa, Stefano, Crutch, Sebastian, Engelborghs, Sebastiaan, Frisoni, Giovanni B, Fox, Nick C, Galasko, Douglas, Habert, Marie-Odile, Jicha, Gregory A, Nordberg, Agneta, Pasquier, Florence, Rabinovici, Gil, Robert, Philippe, Rowe, Christopher, Salloway, Stephen, Sarazin, Marie, Epelbaum, Stéphane, de Souza, Leonardo C, Vellas, Bruno, Visser, Pieter J, Schneider, Lon, Stern, Yaakov, Scheltens, Philip, Cummings, Jeffrey L
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Elsevier Ltd 01.06.2014 Elsevier Limited
Schlagworte:	Alzheimer Disease Alzheimer Disease - diagnosis Alzheimer Disease - genetics Alzheimer Disease - physiopathology Alzheimer's disease analysis Biological Markers Biomarkers Biomarkers - analysis Biomarkers - chemistry chemistry diagnosis Fees & charges genetics Humans Immunotherapy International Cooperation Medical Memory Neurologi Neurology Pathology Pharmaceutical industry Phenotype physiopathology Practice Guidelines as Topic Practice Guidelines as Topic - standards Societies Societies, Medical - standards
ISSN:	1474-4422, 1474-4465, 1474-4465
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!